Mandolin, the leading AI automation platform for specialty drug access, announced that it has raised $40 million in funding from Greylock Partners, SignalFire, Maverick, SV Angel, along with Jerry Yang (co-founder of Yahoo!) and Guillermo Rauch (CEO of Vercel). Founded by repeat entrepreneurs Will Yin (CEO) and Rohit Rustagi (COO), Mandolin is used by many of the nation's largest infusion providers, pharmacies, and health systems..

曼陀林（Mandolin），领先的特种药物获取AI自动化平台，宣布已从Greylock Partners、SignalFire、Maverick、SV Angel以及雅虎联合创始人杨致远和Vercel首席执行官吉列尔莫·劳赫处筹集了4000万美元的资金。曼陀林由连续创业者威尔·尹（首席执行官）和罗希特·鲁斯塔吉（首席运营官）创立，被美国许多最大的输液供应商、药房和卫生系统使用。

Mandolin is the leading AI automation platform for specialty drug access. The company's AI agents act just like a best employee, completing tasks like reasoning about clinical policies, calling payers, parsing faxes and handwritten notes, and making decisions across entire workflows.

曼陀林是领先的特殊药品获取AI自动化平台。该公司的AI代理表现得就像最优秀的员工，完成诸如解读临床政策、联系支付方、解析传真和手写笔记以及在整个工作流程中做出决策等任务。